Genetic variant implicated in lung cancer development also linked with improved outcomes among affected patients

October 18, 2013, RIKEN
Figure 1: A mutation linked to lung cancer in Japanese women who do not smoke is also associated with better clinical outcomes. Credit: iStock/Thinkstock

Lung cancer is the most common cause of cancer death in much of the industrialized world, including Japan. While cigarette smoke is most frequently the source of the disease, genetics can also play a role. Scientists have identified a handful of genetic variants associated with an increased susceptibility to lung cancer among Asian women who do not smoke. A research team led by Toshihisa Ishikawa and colleagues from the RIKEN Center for Life Science Technologies has now identified another gene mutation that puts non-smoking Japanese women at elevated risk of lung cancer, but which is also linked to better prognosis for those who develop the disease.

Genetic variants, referred to by geneticists as (SNPs), can be useful as prognostic biomarkers for guiding diagnoses and personalizing therapies. Ishikawa and his colleagues set out to test whether variants in the NRF2 gene, which encodes a transcription factor involved in cellular antioxidant defense mechanisms, could predict the likelihood of someone developing lung cancer. The researchers analyzed DNA samples from a total of 387 Japanese lung cancer patients—43% women and 40% non-smokers—using a rapid isothermal genetic test developed specifically for this study. The team's rapid genotyping does not require DNA to be isolated or polymerase chain reaction (PCR) amplification and takes only 30–45 minutes to complete.

Looking at position –617 in the NRF2 gene, the researchers identified 24 patients who had two copies of the adenine nucleotide; the rest had at least one cytosine at this location. Of these 24 individuals, 16 were female non-smokers, and all had a type of lung cancer known as adenocarcinoma.

Notably, patients of either gender who carried two copies of adenine at position –617 of the NRF2 gene also had significantly better survival outcomes than other patients. These same individuals were more likely to carry the most common, or 'wild type', version of MDM2, a gene regulated by NRF2 that encodes a negative regulator of p53, an important tumor suppressor protein. Both the –617A variant in the NRF2 gene and the wild-type version of MDM2 are more often found in east Asian populations.

"Genetic testing of these SNPs should be performed to predict the prognosis of patients in east Asian countries, such as Japan, South Korea and China," suggests Ishikawa. "It would be desirable to include such genetic information in each patient's record as guidance for medical doctors to provide individualized treatment."

Explore further: New mutation identified, associated with better survival in lung cancer patients

More information: Okano, Y., et al. SNP (–617C>A) in ARE-like loci of the NRF2 gene: A new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women, PLoS One 8, e73794 (2013). dx.doi.org/10.1371/journal.pone.0073794

Related Stories

New mutation identified, associated with better survival in lung cancer patients

September 11, 2013
Japanese researchers have identified a mutation associated with a higher incidence of lung cancer in Japanese women who do not smoke, but better survival in lung cancer patients. In a study published today in the journal ...

Кesearchers identify gene variations that may help predict cancer treatment response

August 9, 2013
Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more ...

Gene variations linked to lung cancer susceptibility in Asian women

November 11, 2012
An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, ...

Latest research confirms genetic susceptibility to lung cancer

April 15, 2012
Previous research has shown that Asian patients with lung cancer are more likely to harbor epidermal growth factor receptor (EGFR) mutations. Furthermore, Asian patients with lung cancer are more likely to be non-smokers ...

Scientists detail critical role of gene in many lung cancer cases

August 29, 2013
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role in non-small cell lung cancer, ...

MicroRNA molecule found to be a potent tumor-suppressor in lung cancer

September 16, 2013
New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or ...

Recommended for you

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.